News Image

TG THERAPEUTICS INC (NASDAQ:TGTX) – A High Growth Momentum Stock with Strong Technical Setup

By Mill Chart

Last update: Jul 17, 2025

TG THERAPEUTICS INC (NASDAQ:TGTX) has been identified as a high-growth momentum stock with a favorable technical setup. The company, focused on treatments for B-cell malignancies and autoimmune diseases, demonstrates strong earnings momentum alongside a bullish chart pattern. Below, we examine why TGTX stands out for growth investors and technical traders.

TG THERAPEUTICS stock chart

Growth Momentum Highlights

  • Earnings Growth: TGTX reported a 142.9% year-over-year EPS growth in the most recent quarter, following an even stronger 250% growth in the prior quarter.
  • Revenue Expansion: Sales grew by 90.4% quarter-over-quarter, with a trailing twelve-month revenue increase of 33.5%.
  • Profit Margins: The company has shown improving profitability, with a quarterly profit margin of 4.19%, up from negative figures in previous years.
  • Analyst Revisions: While EPS estimates for next year have seen downward revisions, revenue estimates have been revised upward by 4.8% over the past three months.
  • Earnings Surprises: TGTX has beaten revenue estimates in all of the last four quarters, with an average EPS beat of 36.4%.

Technical Strength & Setup

TGTX holds a Technical Rating of 9/10, reflecting strong price momentum and trend health. Key observations from the technical report include:

  • Uptrend Confirmation: Both short-term and long-term trends are positive, with the stock outperforming 90% of the market over the past year.
  • Consolidation Pattern: The stock has been trading in a range between $34.03 and $39.64 over the past month, forming a base near the upper end of this range.
  • Support & Resistance: Key support lies at $36.82-$37.64, while resistance is seen at $40.07. A breakout above $40 could signal further upside.
  • Setup Quality: With a Setup Rating of 8/10, TGTX presents a favorable risk-reward opportunity, with a suggested entry at $40.08 and a stop-loss at $36.81.

Why This Combination Matters

High-growth momentum stocks with strong technical setups often attract institutional interest, as they combine accelerating fundamentals with favorable price action. TGTX fits this profile, making it a candidate for investors following CANSLIM or Minervini-style strategies.

For more high-growth momentum stocks with strong technical setups, check our High Growth Momentum Breakout Setups Screen.

Disclaimer

This is not investment advice. Always conduct your own research and consider risk management before making investment decisions.

TG THERAPEUTICS INC

NASDAQ:TGTX (8/8/2025, 3:45:08 PM)

26.81

-1.08 (-3.87%)



Find more stocks in the Stock Screener

TGTX Latest News and Analysis

Follow ChartMill for more